SH
Shield Therapeutics plc
SHIEF · OTC
$0.09 +0.00% (+$0.00)
Market Cap $91.6M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.11
28.5% upside
Current Price
$0.086
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SHIEF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
81 /100
Cheap P/S 1.80x
PEG N/A
P/E N/A
Growth
100 /100
Growing Rev. growth 123.53%
Book val. growth N/A
EPS growth N/A
Profitability
18 /100
Weak Op. margin 20.29%
Gross margin 44.11%
FCF margin 17.41%
Quality
14 /100
Poor Asset turnover 0.78x
ROIC 70.41%
ROA 27.63%
Debt
13 /100
High Int. coverage -1.36x
Current ratio 0.90x
Debt/Assets N/A
Stability
32 /100
Unstable EPS volatility 18.95%
Beta 1.72x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SHIEF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Anders Lundstrom
Employees
61
Headquarters
Gateshead